1. Home
  2. PCQ vs HUMA Comparison

PCQ vs HUMA Comparison

Compare PCQ & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PIMCO California Municipal Income Fund

PCQ

PIMCO California Municipal Income Fund

SELL

Current Price

$8.01

Market Cap

155.6M

Sector

Finance

ML Signal

SELL

Logo Humacyte Inc.

HUMA

Humacyte Inc.

SELL

Current Price

$0.55

Market Cap

165.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PCQ
HUMA
Founded
2001
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
155.6M
165.7M
IPO Year
2001
2020

Fundamental Metrics

Financial Performance
Metric
PCQ
HUMA
Price
$8.01
$0.55
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
★ $1.64
AVG Volume (30 Days)
190.2K
★ 4.7M
Earning Date
01-01-0001
11-10-2026
Dividend Yield
★ 4.63%
N/A
EPS Growth
N/A
★ 79.37
EPS
★ N/A
N/A
Revenue
N/A
★ $2,038,000.00
Revenue This Year
N/A
$98.07
Revenue Next Year
N/A
$480.72
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.57
$0.34
52 Week High
$9.19
$1.53

Technical Indicators

Market Signals
Indicator
PCQ
HUMA
Relative Strength Index (RSI) 44.49 57.22
Support Level N/A $0.54
Resistance Level $9.16 $0.61
Average True Range (ATR) 0.11 0.06
MACD -0.02 0.02
Stochastic Oscillator 6.36 63.88

Price Performance

Historical Comparison
PCQ
HUMA

About PCQ PIMCO California Municipal Income Fund

PIMCO California Municipal Income Fund is a closed-end management investment company. It seeks to provide current income exempt from federal, New York State, and New York City income tax. The fund invests across sectors including healthcare, property, education, Natural Gas, and others.

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: